Repligen
RGEN
#2562
Rank
HK$52.56 B
Marketcap
HK$933.18
Share price
-2.10%
Change (1 day)
-18.38%
Change (1 year)
Categories

Repligen (RGEN) - Total debt

Total debt on the balance sheet as of September 2025 : HK$5.39 Billion

According to Repligen 's latest financial reports the company's total debt is HK$5.39 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Repligen - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$5.32 B-4.17%
2023-12-31HK$5.55 B68.22%
2022-12-31HK$3.30 B15.78%
2021-12-31HK$2.85 B33.69%
2020-12-31HK$2.13 B4.11%
2019-12-31HK$2.05 B153.05%
2018-12-31HK$0.81 B4.51%
2017-12-31HK$0.77 B4.96%
2016-12-31HK$0.73 B
2005-03-31HK$0.93 M40.18%
2004-03-31HK$0.66 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
HK$476.23 B 8,733.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$279.25 B 5,079.52%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$160.40 B 2,875.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$368.94 B 6,742.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.19 B-96.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$1.96 B-63.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$3.25 B-39.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$2.74 B-49.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$4.72 B-12.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$20.57 B 281.59%๐Ÿ‡บ๐Ÿ‡ธ USA